Ensysce Biosciences, Inc. (ENSC)
NCM · Common · CUSIP 293602108
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for ENSC and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
293602108 (prev. 52539T107 )
Market Cap
Micro Cap
IPO
12/1/2017
Previous Symbol
LACQ (changed 7/2/2021)
Previous Name
Leisure Acquisition Corp
Business: Ensysce Biosciences, Inc. is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. Leveraging its Trypsin Activated Abuse Protection (TAAP™) and Multi-Pill Abuse Resistance (MPAR™) platforms, the Company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses.

Company Contact

CEO
D. Lynn Kirkpatrick
CFO
Dave Humphrey
Headquarters
7946 Ivanhoe Avenue, Suite 201, La Jolla, CA 92037
Phone
858-263-4196
Investor Relations
Shannon Devine, MZ North America · 203-741-8811 · ENSC@mzgroup.us
SEC EDGAR Filings
View filings »